NSC |
Compound |
Enrichment |
Correlation |
NSC 629595 |
Null |
0.0385613993886001 |
0.37996843 |
NSC 633113 |
[1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- |
0.0385613993886001 |
0.42791926 |
NSC 633271 |
Null |
0.0385613993886001 |
0.31237562 |
NSC 633514 |
Null |
0.0385613993886001 |
0.36718677 |
NSC 633963 |
N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride |
0.0385613993886001 |
0.04091237 |
NSC 635449 |
Copper, chloro[2-[1-(2-pyridinyl)ethylidene][N,N-dipropyl-hydrazinecarbothioamidato-N,N,S]- |
0.0385613993886001 |
0.32584917 |
NSC 638409 |
(E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide |
0.0385613993886001 |
0.26790436 |
NSC 63878 |
Cytarabine Hydrochloride AZ |
0.0385613993886001 |
0.49938695 |
NSC 639514 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride |
0.0385613993886001 |
0.5404925 |
NSC 641454 |
3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 |
0.0385613993886001 |
0.32688357 |